Sarah Grimwood

Head of Portfolio, Strategy & Operations - Rare Disease Unit

Sarah Grimwood is responsible for overseeing Rare Disease Research Unit (RDRU) Portfolio progression up to Phase 2 Clinical Proof of Concept and supporting the design of strategies and initiatives to maintain and grow a high-performing research unit.

From 2017 – 2020, Sarah served as the RDRU Chief of Staff and her previous background includes ...


Social

Roles at Pfizer

  • Head of Portfolio, Strategy & Operations - Rare Disease Unit

    Current role

Teams

No teams

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.